Given that TEVA has now gone dark on the subject of tLovenox I don't see that there any way to say much about how 'close to obtaining approval' it is - other than reading of very faint tea leaves. Did I miss something?
The Judge in the Lovenox patent case scheduled a trial for Feb 2013 after determining that Teva was not close to obtaining FDA approval (#msg-64632121).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.